Although the clinical effectiveness and tolerability of BC for treating menopausal symptoms has not been proved in randomized clinical trials, we revealed that the BC extract at the dose of 50 μg/mL could reduce excessive vasodilation through the PGD2 receptor. Here, PTGDR is linked to breast cancer.